by Clinical Neuropsychologist Online | Wednesday, August 26, 2026 | Dementia
Abstract INTRODUCTION We evaluated whether apolipoprotein E (APOE εε4) genotype-guided lecanemab escalation mitigates the APOE εε4–driven amyloid-related imaging abnormalities (ARIA) with edema (ARIA-E) gradient and whether ARIA-E and ARIA with hemosiderin deposition...
by Clinical Neuropsychologist Online | Wednesday, August 26, 2026 | Dementia
Abstract INTRODUCTION Few studies have examined the longitudinal associations between chronic stress, social support, and cognitive decline or whether sociodemographic factors modify associations. METHODS We included 3873 older adults enrolled in the Health and Aging...
by Clinical Neuropsychologist Online | Tuesday, August 25, 2026 | Neuropsychology (general)
Abstract Access to clear, accurate and accessible information is essential for people with disability to exercise choice and control, as outlined in the UN Convention on the Rights of Persons with Disabilities. However, few tools exist to evaluate the quality of...
by Clinical Neuropsychologist Online | Tuesday, August 25, 2026 | Paediatric Neuropsychology
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | August 25, 2026 Neuro-Paediatric Previous Page
by Clinical Neuropsychologist Online | Tuesday, August 25, 2026 | Dementia
Abstract BACKGROUND Polypharmacy, potentially inappropriate medications (PIMs), and drugs associated with drug-induced cognitive impairment (DICI) are highly prevalent in older adults and may affect cognitive decline. METHODS This observational retrospective study...
